company background image
0QIU logo

Novo Nordisk LSE:0QIU Stock Report

Last Price

DKK 778.83

Market Cap

DKK 3.5t

7D

4.2%

1Y

15.5%

Updated

05 Dec, 2024

Data

Company Financials +

0QIU Stock Overview

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. More details

0QIU fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends3/6

Novo Nordisk A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Novo Nordisk
Historical stock prices
Current Share PriceDKK 778.83
52 Week HighDKK 1,032.20
52 Week LowDKK 645.70
Beta0.17
11 Month Change4.96%
3 Month Change-12.08%
1 Year Change15.53%
33 Year Change107.47%
5 Year Change308.35%
Change since IPO192.24%

Recent News & Updates

Recent updates

Shareholder Returns

0QIUGB PharmaceuticalsGB Market
7D4.2%-0.2%0.7%
1Y15.5%1.0%8.6%

Return vs Industry: 0QIU exceeded the UK Pharmaceuticals industry which returned 1% over the past year.

Return vs Market: 0QIU exceeded the UK Market which returned 8.6% over the past year.

Price Volatility

Is 0QIU's price volatile compared to industry and market?
0QIU volatility
0QIU Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0QIU has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0QIU's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192371,880Lars Jorgensenwww.novonordisk.com

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas.

Novo Nordisk A/S Fundamentals Summary

How do Novo Nordisk's earnings and revenue compare to its market cap?
0QIU fundamental statistics
Market capDKK 3.45t
Earnings (TTM)DKK 94.72b
Revenue (TTM)DKK 270.58b

36.4x

P/E Ratio

12.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0QIU income statement (TTM)
RevenueDKK 270.58b
Cost of RevenueDKK 41.51b
Gross ProfitDKK 229.07b
Other ExpensesDKK 134.35b
EarningsDKK 94.72b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)21.41
Gross Margin84.66%
Net Profit Margin35.01%
Debt/Equity Ratio47.3%

How did 0QIU perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

47%

Payout Ratio